Inicio | Buscar

Buscar

Resultados de la búsqueda

Vidatox 30CH in advanced malignant tumors-Primary health care-Phase IV

... Dr. Eva Salomon Zaldívar, First degree specialist in Oncology, Observatory of Cancer Coordinator ...

Clinical Trials - LABIOFAM - 23/06/2013 - 3:03am

Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study)

... Aldereguía Lima”, Cienfuegos, February 24, 2009. - Oncology Hospital “Celestino Hernández Robau”, Villa Clara. April 21, ...

Clinical Trials - CIGB - 23/06/2013 - 2:59am

Nimotuzumab en tumores de cabeza y cuello.Fase IV

... TS, Rosenberg SA: Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011, pp ... TS, Rosenberg SA: Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011, pp ...

Ensayos Clínicos - CIMAB - 08/04/2013 - 4:37pm

Nimotuzumab en el tratamiento de tumores de alto grado de malignidad.

... T, Rosenberg S. Cancer: Principles and Practice of Oncology. 9th ed. ed. Philadelphia, Pa; 2011. 2.Bondy ML, Scheurer ME, Malmer ...

Ensayos Clínicos - CIMAB - 08/04/2013 - 4:37pm

Nimotuzumab- Cáncer de cabeza y cuello

... squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 1992;10:1245–51. Clavel M, Vermorken JB, ... (E1395): An Intergroup Trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2005;23(15):3562-3567. FDA Approves New Treatment ...

Ensayos Clínicos - CIMAB - 08/04/2013 - 2:10pm

Efectividad y seguridad del uso del ior leukoCIM como profilaxis y tratamiento de la Neutropenia en pacientes VIH/SIDA.

... kinetic. American Journal of Pediatric Hematology/Oncology 11: 238-244, 1989. 11.Demetri GD, Griffin JD. Granulocyte colony ... dose-finding study in women with breast cancer. Annals of Oncology 13:903-909, 2002. 60. Stull D, Bilmes R, Kim H, Fichtl R. Comparison ...

Ensayos Clínicos - CIMAB - 08/04/2013 - 2:09pm

Impacto del Factor Estimulante de Colonias Granulocíticas (ior-Leukocim) en profilaxis primaria, secundaria y neutropenia post-quimioterapia o radioterapia en pacientes pediátricos oncohematológicos.

... Clinical Practice Guidelines. Journal of Clinical Oncology: Vol 18 No 20: pp 3558-3585, 2000. 12.Naranjo CA, Busto UE. Reacciones ...

Ensayos Clínicos - CIMAB - 08/04/2013 - 2:09pm

Evaluación de seguridad del Factor Estimulante de Colonias Granulocíticas (ior-LeukoCIM) en pacientes oncohematológicos. Estudio fase IV.

... Clinical Practice Guidelines. Journal of Clinical Oncology: Vol 18 No 20: pp 3558-3585, 2000. 2.Decoster G, Rich W. Tolerability ... dose-finding study in women with breast cancer. Annals of Oncology 13:903-909, 2002. 43. Scott S, Chrischilles E, Link B, Delgado D, ...

Ensayos Clínicos - CIMAB - 08/04/2013 - 2:09pm

Impacto de la Eritropoyetina Humana Recombinante (ior EPOCIM) en Pacientes Oncológicos Pediátricos portadores de Anemia post-quimio y/o radioterapia.

... Inst 93:1204-1214, 2001. 7.American Society of Clinical Oncology: Outcomes of cancer treatment for technology assessment and cancer ... practice guidelines of American Society of Clinical Oncology (ASCO) and American Society of Hematlogy (AHO). J Clin Oncol 2002. Vol ...

Ensayos Clínicos - CIMAB - 08/04/2013 - 2:06pm

Impacto de la Eritropoyetina Humana Recombinante (ior EPOCIM) en pacientes oncológicos portadores de anemia post-quimio y /o radioterapia.

... Inst 93:1204-1214, 2001. 7.American Society of Clinical Oncology: Outcomes of cancer treatment for technology assessment and cancer ... practice guidelines of American Society of Clinical Oncology (ASCO) and American Society of Hematlogy (AHO). J Clin Oncol 2002. Vol ...

Ensayos Clínicos - CIMAB - 08/04/2013 - 2:06pm